Sunbelt Securities, Inc. Amgen Inc Transaction History

Sunbelt Securities, Inc.

$1.28 Billion
Q3 2025

A detailed history of Sunbelt Securities, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Sunbelt Securities, Inc. holds 7,114 shares of AMGN stock, worth $2.43 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

7,114

Previous 6,704 6.12%

Holding current value

$2.43 Million

Previous $1.87 Million 7.27%

% of portfolio

0.16%

Previous 0.17%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 19, 2025	BUY	$271.18 - $309.22 $111,183 - $126,780	410 Added 6.12%	7,114 $2.01 Million
Q2 2025 Aug 14, 2025	BUY	$262.28 - $309.85 $29,899 - $35,322	114 Added 1.73%	6,704 $1.87 Million
Q1 2025 Apr 24, 2025	SELL	$258.59 - $327.36 $34,392 - $43,538	-133 Reduced 1.98%	6,590 $2.05 Million
Q4 2024 Feb 18, 2025	BUY	$258.78 - $328.31 $530,757 - $673,363	2,051 Added 43.9%	6,723 $1.75 Million
Q3 2024 Nov 18, 2024	BUY	$309.38 - $337.38 $71,157 - $77,597	230 Added 5.18%	4,672 $1.51 Million

Q2 2024 Aug 15, 2024	SELL	$262.75 - $319.31 $252,240 - $306,537	-960 Reduced 17.77%	4,442 $1.39 Million
Q1 2024 Apr 15, 2024	SELL	$268.87 - $324.56 $19,627 - $23,692	-73 Reduced 1.33%	5,402 $1.54 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $74,920 - $84,518	-293 Reduced 5.08%	5,475 $1.58 Million
Q3 2023 Dec 11, 2023	SELL	$218.65 - $271.46 $1,093 - $1,357	-5 Reduced 0.09%	5,768 $1.55 Million
Q2 2023 Aug 15, 2023	BUY	$214.27 - $253.37 $87,636 - $103,628	409 Added 7.62%	5,773 $1.28 Million
Q1 2023 May 17, 2023	BUY	$225.79 - $275.2 $139,086 - $169,523	616 Added 12.97%	5,364 $1.3 Million
Q4 2022 Feb 08, 2023	BUY	$229.03 - $291.01 $27,941 - $35,503	122 Added 2.64%	4,748 $1.25 Million
Q3 2022 Nov 21, 2022	BUY	$224.46 - $253.15 $44,443 - $50,123	198 Added 4.47%	4,626 $1.04 Million
Q2 2022 Oct 03, 2022	BUY	$230.71 - $256.74 $58,138 - $64,698	252 Added 6.03%	4,428 $1.08 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $344,911 - $381,562	-1,573 Reduced 27.36%	4,176 $1.01 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $206,636 - $236,476	-1,039 Reduced 15.31%	5,749 $1.39 Million
Q2 2021 Jul 29, 2021	SELL	$233.58 - $259.14 $132,439 - $146,932	-567 Reduced 7.71%	6,788 $1.68 Million
Q1 2021 May 27, 2021	SELL	$221.91 - $258.6 $2,441 - $2,844	-11 Reduced 0.15%	7,355 $1.83 Million
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $416,315 - $495,757	1,924 Added 35.35%	7,366 $1.69 Million
Q3 2020 Nov 17, 2020	BUY	$234.65 - $260.95 $72,272 - $80,372	308 Added 6.0%	5,442 $1.38 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $259,526 - $318,474	-1,312 Reduced 20.35%	5,134 $1.21 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $749,006 - $993,387	-4,110 Reduced 38.94%	6,446 $1.33 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $728,836 - $936,806	-3,852 Reduced 26.74%	10,556 $636 Million
Q3 2019 Nov 15, 2019	BUY	$174.11 - $208.62 $1.62 Million - $1.94 Million	9,317 Added 183.01%	14,408 $2.79 Million
Q2 2019 Aug 01, 2019	SELL	$166.7 - $195.41 $364,072 - $426,775	-2,184 Reduced 30.02%	5,091 $938,000
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $427,034 - $481,360	2,361 Added 48.05%	7,275 $1.38 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $132,551 - $154,729	-743 Reduced 13.13%	4,914 $957,000
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $114,694 - $129,302	619 Added 12.29%	5,657 $1.17 Million
Q2 2018 Aug 08, 2018	BUY	$166.05 - $186.51 $100,626 - $113,025	606 Added 13.67%	5,038 $930,000
Q1 2018 May 09, 2018	BUY	$169.43 - $198.0 $150,114 - $175,428	886 Added 24.99%	4,432 $756,000
Q4 2017 Feb 06, 2018	BUY	$168.79 - $188.59 $598,529 - $668,740	3,546	3,546 $617,000

Others Institutions Holding AMGN

# of Institutions

3,273

Shares Held

428M

Call Options Held

6.11M

Put Options Held

5.85M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $183B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sunbelt Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sunbelt Securities, Inc. with notifications on news.

Account

Sunbelt Securities, Inc. Amgen Inc Transaction History